FCPM III SERVICES B.V.
Q3 2025 13F Holdings
- Locationnaarden, P7
- Num holdings
9
- Value ($000)
$500,389
- Date Filed11/14/2025
- Form type13F-HR
- CIK0002013410
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | $262.00 M | 52 % | 9,212,384 | ||
DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $69.11 M | 14 % | 5,462,846 | ||
ENGN ENGENE HOLDINGS INC | COM | 29286M105 | $65.79 M | 13 % | 9,632,561 | ||
ATXS ASTRIA THERAPEUTICS INC | COM | 04635X102 | $29.90 M | 6 % | 4,107,537 | ||
BCYC BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | $26.72 M | 5 % | 3,452,330 | ||
VOR BIOPHARMA INC | COM NEW | 929033207 | $18.50 M | 4 % | 379,640 | ||
REPL REPLIMUNE GROUP INC | COM | 76029N106 | $17.42 M | 4 % | 4,158,368 | ||
RAPT THERAPEUTICS INC | COM NEW | 75382E208 | $8.88 M | 2 % | 344,237 | ||
ENGNW ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | $2.07 M | 0 % | 2,878,148 |
Rows Per Page
10
- 10
- 50
- 100